fluphenazine has been researched along with Atherosclerotic Parkinsonism in 44 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A trial involving patients receiving fluphenazine decanoate was designed to compare the effects of orphenadrine hydrochloride (Disipal) and its major metabolite, tofenacin hydrochloride (Elamol) on the Parkinsonian side-effects and depression occurring during fluphenazine decanoate therapy." | 9.04 | A comparative trial of orphenadrine and tofenacin in the control of depression and extrapyramidal side-effects associated with fluphenazine decanoate therapy. ( Capstick, N; Pudney, H, 1976) |
| "/day) versus fixed standard dosage (20 mg." | 6.64 | High vs standard dosage fluphenazine HCL in acute schizophrenia. ( Donlon, PT; Meadow, A; Tupin, JP; Wahba, M, 1978) |
| "A double-blind, cross-over trial of the effectiveness of piribedil, procyclidine and placebo in the control of parkinsonism induced by fluphenazine decanoate was conducted in sixteen cases of chronic schizophrenia." | 5.04 | A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism. ( Bradley, R; Lamb, P; Mindham, RH, 1977) |
| "A trial involving patients receiving fluphenazine decanoate was designed to compare the effects of orphenadrine hydrochloride (Disipal) and its major metabolite, tofenacin hydrochloride (Elamol) on the Parkinsonian side-effects and depression occurring during fluphenazine decanoate therapy." | 5.04 | A comparative trial of orphenadrine and tofenacin in the control of depression and extrapyramidal side-effects associated with fluphenazine decanoate therapy. ( Capstick, N; Pudney, H, 1976) |
| "During long-term treatment of schizophrenia with antipsychotic medication, side effects such as weight gain and tardive dyskinesia may develop, while other extrapyramidal side effects may continue." | 2.67 | Side effects during long-term treatment with depot antipsychotic medication. ( Cookson, JC, 1991) |
| " Improvement was recorded in a double blind study of 18 patients treated with maximum tolerated dosage (mean 18." | 2.64 | Tardive dyskinesia treated with pimozide. ( Calne, DB; Claveria, LE; Haskayne, L; Lodge-Patch, IC; Pallis, CA; Petrie, A; Teychenne, PF, 1975) |
| "/day) versus fixed standard dosage (20 mg." | 2.64 | High vs standard dosage fluphenazine HCL in acute schizophrenia. ( Donlon, PT; Meadow, A; Tupin, JP; Wahba, M, 1978) |
| "We report the singular case of a 31-year-old woman who developed very serious Fluphenazine-induced parkinsonism over a few days due to a doubly incongruent drug prescription by indication and dosage having been applied to a healthy subject over one week instead of seven months." | 1.91 | Fluphenazine-Induced Neurotoxicity with Acute Almost Transient Parkinsonism and Permanent Memory Loss: Lessons from a Case Report. ( Costa, MC; De Masi, R; Orlando, S; Toni, V, 2023) |
| "A patient with schizoaffective disorder and anticholinergic refractory neuroleptic-induced parkinsonism manifested a marked increase of parkinsonian symptoms and dystonia after ECT." | 1.29 | An unusual effect of ECT on drug-induced parkinsonism and tardive dystonia. ( Hanin, B; Lerner, Y; Srour, N, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (88.64) | 18.7374 |
| 1990's | 4 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (2.27) | 2.80 |
| Authors | Studies |
|---|---|
| De Masi, R | 1 |
| Orlando, S | 1 |
| Toni, V | 1 |
| Costa, MC | 1 |
| Sheppard, C | 1 |
| Merlis, S | 1 |
| Barnes, TR | 2 |
| Wiles, DH | 1 |
| Hanin, B | 1 |
| Lerner, Y | 1 |
| Srour, N | 1 |
| Dhopesh, V | 1 |
| Macfadden, A | 1 |
| Maany, I | 1 |
| Gamble, G | 1 |
| Mindham, RH | 4 |
| Small, JG | 1 |
| Kellams, JJ | 1 |
| Milstein, V | 1 |
| Klapper, M | 1 |
| Lemberger, L | 1 |
| Chouinard, G | 2 |
| Annable, L | 2 |
| Ross-Chouinard, A | 2 |
| Nestoros, JN | 1 |
| Kropsky, ML | 1 |
| Lamb, P | 2 |
| Ezzat, MA | 1 |
| Claveria, LE | 1 |
| Teychenne, PF | 1 |
| Calne, DB | 1 |
| Haskayne, L | 1 |
| Petrie, A | 1 |
| Pallis, CA | 1 |
| Lodge-Patch, IC | 1 |
| Martin, IC | 1 |
| Bradley, R | 1 |
| Frangos, H | 1 |
| Zissis, NP | 1 |
| Leontopoulos, I | 1 |
| Diamantas, N | 1 |
| Tsitouridis, S | 1 |
| Gavriil, I | 1 |
| Tsolis, K | 1 |
| Donlon, PT | 1 |
| Meadow, A | 1 |
| Tupin, JP | 1 |
| Wahba, M | 1 |
| Jose, C | 1 |
| Mallya, A | 1 |
| Mehta, D | 1 |
| Evenson, R | 1 |
| Holland, R | 1 |
| Raskind, M | 1 |
| Alvarez, C | 1 |
| Herlin, S | 1 |
| Capstick, N | 1 |
| Pudney, H | 1 |
| De Fraites, EG | 1 |
| Davis, KL | 1 |
| Berger, PA | 1 |
| Gelenberg, AJ | 1 |
| Mandel, MR | 1 |
| Schulz, HD | 1 |
| Kluge, HH | 1 |
| Korda, W | 1 |
| Kube, B | 1 |
| Cookson, JC | 1 |
| Brewer, BD | 1 |
| Hines, MT | 1 |
| Stewart, JT | 1 |
| Langlois, JF | 1 |
| Hirschberg, E | 1 |
| Curson, DA | 1 |
| Bamber, RW | 1 |
| Platt, SD | 1 |
| Hirsch, SR | 1 |
| Duffy, JC | 1 |
| Escande, M | 1 |
| Vasquez Villareal, S | 1 |
| Gayral, L | 1 |
| Whittier, JR | 1 |
| Korenyi, C | 1 |
| Boelkins, RC | 1 |
| Bordeleau, JM | 1 |
| Tétreault, L | 1 |
| Davidson, J | 1 |
| Gaind, R | 1 |
| Anstee, BH | 1 |
| Rimmer, L | 1 |
| Ayd, FJ | 1 |
| Itil, TM | 1 |
| Patterson, CD | 1 |
| Keskiner, A | 1 |
| Holden, JM | 1 |
| Angst, J | 1 |
| Frei, M | 1 |
| Dreyfuss, J | 1 |
| Beer, B | 1 |
| Devine, DD | 1 |
| Roberts, BF | 1 |
| Schreiber, EC | 1 |
| Schwingenheuer, J | 1 |
| Johnson, DA | 1 |
| Engstrand, E | 1 |
| Morris, PA | 1 |
| MacKenzie, DH | 1 |
| Masheter, HC | 1 |
| Haddenbrock, S | 1 |
| Náhunek, K | 1 |
| Rodová, A | 1 |
| Svestka, J | 1 |
| Simpson, GM | 1 |
| Kurland, AA | 1 |
| Dim, BH | 1 |
| Olsson, JE | 1 |
| West, D | 1 |
1 review available for fluphenazine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Side effects of depot fluphenazines.
Topics: Agranulocytosis; Barbiturates; Basal Ganglia Diseases; Benztropine; Biperiden; Delayed-Action Prepar | 1974 |
16 trials available for fluphenazine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Assessment of drugs in schizophrenia. Asessment of drug-induced extrapyramidal reactions and of drugs given for their control.
Topics: Amantadine; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as T | 1976 |
Effects of lergotrile on schizophrenia & drug induced parkinsonism.
Topics: Acetonitriles; Adult; Antiparkinson Agents; Antipsychotic Agents; Chronic Disease; Clinical Trials a | 1977 |
Ethopropazine and benztropine in neuroleptic-induced parkinsonism.
Topics: Adult; Benztropine; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; | 1979 |
Tardive dyskinesia treated with pimozide.
Topics: Aged; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Consciousnes | 1975 |
Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Delayed-Action Preparat | 1975 |
A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism.
Topics: Chronic Disease; Clinical Trials as Topic; Fluphenazine; Humans; Parkinson Disease; Parkinson Diseas | 1977 |
Double-blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Fluphenazine; Fluspir | 1978 |
High vs standard dosage fluphenazine HCL in acute schizophrenia.
Topics: Acute Disease; Adult; Benztropine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Doubl | 1978 |
A comparative trial of orphenadrine and tofenacin in the control of depression and extrapyramidal side-effects associated with fluphenazine decanoate therapy.
Topics: Clinical Trials as Topic; Depression; Fluphenazine; Humans; Orphenadrine; Parkinson Disease, Seconda | 1976 |
Side effects during long-term treatment with depot antipsychotic medication.
Topics: Akathisia, Drug-Induced; Delayed-Action Preparations; Double-Blind Method; Dyskinesia, Drug-Induced; | 1991 |
Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial. II. The incidence of compliance problems, side-effects, neurotic symptoms and depression.
Topics: Clinical Trials as Topic; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Dys | 1985 |
Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism.
Topics: Affect; Amantadine; Basal Ganglia Diseases; Clinical Trials as Topic; Evaluation Studies as Topic; F | 1972 |
Comparison of phenothiazine and nonphenothiazine neuroleptics according to psychopathology, side effects and computerized EEG.
Topics: Alpha Rhythm; Chronic Disease; Clinical Trials as Topic; Computers; Electroencephalography; Female; | 1974 |
[The depot neuroleptic agent fluspirilene (author's transl)].
Topics: Basal Ganglia Diseases; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Female; Fluoroben | 1973 |
[Fluphenazine enanthate in long term treatment of psychoses].
Topics: Clinical Trials as Topic; Fluphenazine; Humans; Male; Parkinson Disease, Secondary; Psychotic Disord | 1969 |
A comparative double blind trial of pimozide and fluphenazine in chronic schizophrenia.
Topics: Benzimidazoles; Blood Cell Count; Clinical Trials as Topic; Fluphenazine; Humans; Male; Middle Aged; | 1970 |
27 other studies available for fluphenazine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Fluphenazine-Induced Neurotoxicity with Acute Almost Transient Parkinsonism and Permanent Memory Loss: Lessons from a Case Report.
Topics: Adult; Amnesia; Antipsychotic Agents; Female; Fluphenazine; Humans; Memory Disorders; Parkinson Dise | 2023 |
Drug-induced extrapyramidal symptoms: their incidence and treatment.
Topics: Chlorpromazine; Chlorprothixene; Extrapyramidal Tracts; Female; Fluphenazine; Humans; Male; Parasymp | 1967 |
Variation in oro-facial tardive dyskinesia during depot antipsychotic drug treatment.
Topics: Aged; Antipsychotic Agents; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Fluphenaz | 1983 |
An unusual effect of ECT on drug-induced parkinsonism and tardive dystonia.
Topics: Adult; Antipsychotic Agents; Dystonia; Electroconvulsive Therapy; Fluphenazine; Humans; Male; Parkin | 1995 |
Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Cocaine; Comorbidity; Delayed-Action Preparations; Flu | 1997 |
Factors related to tardive dyskinesia.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Fluphenazine; Foll | 1979 |
Letter: Parkinsonism induced by fluphenazine decanoate.
Topics: Fluphenazine; Humans; Parkinson Disease, Secondary; Schizophrenia; Time Factors | 1976 |
Iatrogenic morbidity in patients taking depot fluphenazine.
Topics: Adult; Age Factors; Aged; Akathisia, Drug-Induced; Basal Ganglia Diseases; Delayed-Action Preparatio | 1979 |
Fluphenazine enanthate in the outpatient treatment of late paraphrenia.
Topics: Aged; Ambulatory Care; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Injec | 1979 |
Coexisting tardive dyskinesia and parkinsonism: a case report.
Topics: Acetylcholine; Adult; Benztropine; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Fluphenazine | 1977 |
Catatonic reactions to high-potency neuroleptic drugs.
Topics: Adolescent; Adult; Amantadine; Catatonia; Dose-Response Relationship, Drug; Female; Fluphenazine; Ha | 1977 |
[Treatment of schizophrenic psychoses with Lyorodin].
Topics: Acute Disease; Chronic Disease; Female; Fluphenazine; Humans; Male; Parkinson Disease, Secondary; Sc | 1977 |
Fluphenazine induced Parkinson-like syndrome in a horse.
Topics: Animals; Female; Fluphenazine; Horse Diseases; Horses; Parkinson Disease, Secondary | 1990 |
Long persisting drug-induced parkinsonism--a case report.
Topics: Adult; Chronic Disease; Delayed-Action Preparations; Female; Fluphenazine; Humans; Parkinson Disease | 1987 |
[Incidents and accidents during therapy with long-acting neuroleptics].
Topics: Amenorrhea; Autonomic Nervous System; Body Weight; Delayed-Action Preparations; Depression; Eye Mani | 1974 |
Effect of oral fluphenazine on Huntington's chorea.
Topics: Age Factors; Aged; Chronic Disease; Female; Fluphenazine; Humans; Huntington Disease; Male; Mental P | 1968 |
Reactions to fluphenazine hydrochloride by two adult male macaques.
Topics: Aggression; Animals; Behavior, Animal; Drinking Behavior; Drug Tolerance; Feeding Behavior; Fluphena | 1971 |
[Study of extrapyramidal manifestations induced by neuroleptics].
Topics: Antiparkinson Agents; Chlorpromazine; Drug Synergism; Extrapyramidal Tracts; Fluphenazine; Haloperid | 1972 |
Letter: Possible effects of combining phenothiazines.
Topics: Antiparkinson Agents; Drug Therapy, Combination; Fluphenazine; Humans; Male; Middle Aged; Parkinson | 1974 |
Fluphenazine-induced parkinsonism in the baboon: pharmacological and metabolic studies.
Topics: Animals; Basal Ganglia Diseases; Benztropine; Carbon Isotopes; Chromatography, Thin Layer; Feces; Fe | 1972 |
[Clinical experiences with a delayed-action preparation of fluphenazine].
Topics: Administration, Oral; Adult; Aged; Basal Ganglia Diseases; Bipolar Disorder; Climacteric; Delayed-Ac | 1972 |
The side-effects of fluphenazine decanoate.
Topics: Adolescent; Adult; Age Factors; Aged; Female; Fluphenazine; Follow-Up Studies; Humans; Hypotension; | 1973 |
[On the mode of action and the question of central organic late damages of continuous neuroleptic treatment].
Topics: Aged; Brain Stem; Butyrophenones; Central Nervous System; Cerebral Ventriculography; Extrapyramidal | 1966 |
[Clinical experience with fluphenazine decanoate in psychoses].
Topics: Adolescent; Adult; Depressive Disorder, Major; Female; Fluphenazine; Humans; Male; Middle Aged; Para | 1970 |
Long-acting, antipsychotic agents and extrapyramidal side effects.
Topics: Delayed-Action Preparations; Extrapyramidal Tracts; Fluphenazine; Humans; Movement Disorders; Parasy | 1970 |
The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics.
Topics: Administration, Oral; Adult; Biperiden; Chronic Disease; Female; Fluphenazine; Humans; Infusions, Pa | 1970 |
Dangers of fluphenazine.
Topics: Depression; Fluphenazine; Humans; Nausea; Parkinson Disease, Secondary; Vomiting | 1970 |